SCHEMBL8554190

SCHEMBL8554190

CSc1ccc(OC2CC(=O)N2CC(=O)NCCCCCCc2ccccc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 2/20 0.43
KMT2A Q03164 5/20 0.42
MEN1 O00255 3/20 0.42
ALDH1A1 P00352 2/20 0.41
HPGD P15428 1/20 0.41
PKM P14618 1/20 0.40
ASAH1 Q13510 1/20 0.40
LMNA P02545 4/20 0.39
TSHR P16473 1/20 0.39
GAA P10253 1/20 0.39
GFER P55789 1/20 0.39
OPRM1 P35372 1/20 0.39
OPRD1 P41143 1/20 0.39
TP53 P04637 1/20 0.39
POLB P06746 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8552106 0.90 TRPV1 (0.50) TRPV1KMT2AALDH1A1HPGDASAH1
SCHEMBL27499495 0.90 LMNA (0.48) TRPV1KMT2AMEN1ALDH1A1ASAH1
SCHEMBL8553916 0.88 ADAMTS5 (0.48) TRPV1ALDH1A1ASAH1LMNATSHR
SCHEMBL8552214 0.85 TRPV1 (0.42) TRPV1KMT2AMEN1ALDH1A1HPGD
SCHEMBL8553418 0.85 TRPV1 (0.43) TRPV1KMT2AMEN1ALDH1A1HPGD
SCHEMBL8554387 0.82 TRPV1 (0.46) TRPV1KMT2AMEN1ALDH1A1HPGD
SCHEMBL8553467 0.81 LMNA (0.48) TRPV1KMT2AALDH1A1HPGDASAH1
SCHEMBL8442245 0.80 LMNA (0.47) TRPV1KMT2AMEN1ALDH1A1ASAH1
SCHEMBL8551155 0.80 TRPV1 (0.50) TRPV1KMT2AALDH1A1HPGDASAH1
SCHEMBL8555006 0.80 TRPV1 (0.46) TRPV1KMT2AMEN1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0840725-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1998-05-13 EP disclosed
WO-1997002242-A1 AZETIDINONE DERIVATIVES FOR THE TREATMENT OF ATHEROSCLEROSIS SMITHKLINE BEECHAM PLC (GB) 1997-01-23 WO disclosed